Recombinant carboxylate-amine ligases are a diverse superfamily of enzymes known for their ATP-dependent carboxylate-amine ligase activity . These enzymes catalyze the formation of carbon-nitrogen bonds between carboxylate and amine groups, utilizing ATP as an energy source . The catalytic mechanisms often involve acylphosphate intermediates .
The superfamily of ATP-dependent carboxylate-amine ligases possesses a unique nucleotide-binding fold, often referred to as the palmate or ATP-grasp fold . This structural motif is found in various enzymes with diverse functions . Examples include:
These enzymes participate in a wide array of biochemical pathways, reflecting the diversity of their substrates and functions . A notable example is L-aspartate-L-methionine ligase (LdmS), which demonstrates high selectivity for L-aspartate and L-methionine, forming an L-aspartyl-L-methionine dipeptide . The mechanism of LdmS is similar to other ATP-grasp enzymes but has a unique active site architecture that allows selectivity for L-Asp and L-Met substrates .
L-aspartate-L-methionine ligase (LdmS) is a novel L-amino acid ligase (LAL) identified in Staphylococcus aureus NCTC 8325 . LdmS catalyzes the synthesis of the hetero-dipeptide product L-Asp-L-Met . It is the first reported LAL to preferentially accept L-Asp as the carboxylate substrate .
The substrate specificity of SAOUHSC_02373 was screened against the 20 common L-amino acids, which confirmed its LAL activity and preference for L-Met and L-Asp as substrates . Further, modifications of the L-Asp amino and α-carboxylate groups were poorly accommodated, with L-malate, Gly-L-Asp, and L-Asp-Gly being inactive, while N-carbamoyl-DL-Asp displayed 100-fold lower activity than with L-Asp .
Several methods are used to study carboxylate-amine ligases, including:
Antibiotic Resistance: Small molecule inhibitors of the SOS response have the potential to address the threat of antibiotic resistance in bacteria .
Anticancer Evaluation: Certain chemical compounds, such as (E)-5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides, have been evaluated for their anticancer properties .
Inhibitors of Protein-Protein Interaction: Tri-substituted 1,2,4-triazoles have been identified as inhibitors of the annexin A2–S100A10 protein interaction, which may have potential therapeutic benefits in cancer .
Drug Discovery: Research on semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1) has led to the identification of novel efficient substrates that can be used as leads for the discovery of antidiabetic agents .
KEGG: sma:SAVERM_999
STRING: 227882.SAV_999
SAV_999 belongs to the ATP-dependent carboxylate-amine/thiol ligase superfamily, specifically categorized as an L-amino acid ligase (LAL). This enzyme class catalyzes the formation of α-dipeptides from L-amino acids through ATP-dependent reactions. Like other members of this superfamily, SAV_999 contains the characteristic ATP-grasp motif, which plays a crucial role in binding and hydrolyzing ATP to ADP during the peptide bond formation process . The enzyme functions by activating the carboxyl group of one amino acid using ATP, forming an acyl-phosphate intermediate, which then reacts with the amino group of a second amino acid to form a peptide bond.
SAV_999 shares fundamental catalytic mechanisms with other L-amino acid ligases but demonstrates unique substrate specificities. While YwfE from B. subtilis exhibits broad substrate specificity, accepting 111 combinations out of 231 tested L-amino acid pairs , SAV_999 likely has a more restricted substrate range similar to LdmS from S. aureus, which shows high selectivity for specific amino acid combinations (L-aspartate and L-methionine) . This selectivity arises from distinctive structural features in the binding pocket that accommodate particular amino acid side chains. The catalytic efficiency (kcat/Km) values for SAV_999 would differ from both YwfE and LdmS, reflecting its evolutionary adaptation to specific metabolic pathways in its native organism.
L-amino acid ligases represent an evolutionarily distinct mechanism for peptide bond formation compared to ribosomal protein synthesis. The presence of these enzymes appears to be largely restricted to Gram-positive bacteria, with notable conservation among Firmicutes . Their specificity for L-amino acids and inability to utilize D-amino acids as substrates suggests a specialized role in bacterial metabolism. The highly conserved nature of these enzymes within specific bacterial lineages indicates their importance in survival or competitive advantage. For SAV_999, phylogenetic analysis would likely reveal close homology with ligases from related bacterial species, suggesting conservation of function in specific metabolic pathways, potentially involving sulfur-containing amino acids or other specialized metabolic functions.
Recommended Expression Protocol:
Clone the SAV_999 gene into a pQE60 vector or similar expression system with a C-terminal His-tag for purification
Transform into E. coli DH5α or BL21(DE3) strains
Culture in LB medium supplemented with appropriate antibiotics at 37°C until OD600 reaches 0.6-0.8
Induce expression with 0.5-1.0 mM IPTG
Continue cultivation at 25-30°C for 4-6 hours to minimize inclusion body formation
Purification Protocol:
Harvest cells by centrifugation (5,000 × g, 15 min, 4°C)
Resuspend in buffer containing 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 10 mM imidazole
Lyse cells by sonication or pressure homogenization
Clarify lysate by centrifugation (15,000 × g, 30 min, 4°C)
Apply supernatant to Ni-NTA column
Wash with buffer containing 20-50 mM imidazole
Elute with buffer containing 250-300 mM imidazole
Dialyze against 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 5 mM MgCl2, 10% glycerol
This method should yield >95% pure protein suitable for enzymatic assays and structural studies, as demonstrated with similar enzymes like YwfE .
Standard Activity Assay:
Reaction Components:
50 mM Tris-HCl buffer (pH 8.0)
10 mM MgCl2
5 mM ATP
5-10 mM of each amino acid substrate
1-5 μg purified SAV_999 enzyme
Total volume: 100 μL
Reaction Conditions:
Incubate at 37°C for 1-4 hours
Terminate reaction by heating at 95°C for 5 min or adding equal volume of methanol
Product Analysis Methods:
Data Analysis:
Calculate specific activity as μmol of dipeptide formed per minute per mg of enzyme. For kinetic parameters, vary substrate concentrations and fit data to appropriate enzyme kinetic models.
Table 1: Expected Activity Parameters for SAV_999 Based on Related Enzymes
| Parameter | Value Range | Notes |
|---|---|---|
| Optimal pH | 7.5-8.5 | Buffer composition affects activity |
| Optimal temperature | 30-37°C | Stability decreases above 40°C |
| Km for preferred amino acids | 0.5-5 mM | Substrate-dependent variation |
| kcat | 1-10 min⁻¹ | Lower than ribosomal peptide synthesis |
| ATP:dipeptide stoichiometry | 1:1 | Confirms ATP-grasp mechanism |
| Metal ion requirement | Mg²⁺ or Mn²⁺ | Essential for ATP binding |
A comprehensive substrate specificity profile can be established using a matrix-based approach similar to that employed for YwfE characterization :
Substrate Panel Preparation:
Select 20 standard L-amino acids plus relevant derivatives
Create a matrix of all possible binary combinations (400 total)
Prepare stock solutions of each amino acid at 100 mM in appropriate buffer
High-Throughput Screening Protocol:
Perform reactions in 96-well plate format
Include standard reaction components with varying amino acid pairs
Incubate under standard conditions (37°C, 4 hours)
Product Detection Methods:
Primary screening by MALDI-TOF mass spectrometry for dipeptide formation
Secondary confirmation by HPLC for promising combinations
Quantitative analysis of reaction yields for positive hits
Data Organization and Analysis:
Generate a heat map representing reaction efficiency for each amino acid combination
Classify substrates as preferred (>50% conversion), acceptable (10-50% conversion), or poor (<10% conversion)
Identify structural features conferring substrate preference
This systematic approach will reveal the complete substrate profile of SAV_999, enabling comparison with related LALs and providing insights into its biological function .
The substrate specificity of SAV_999 is likely determined by key structural elements in the binding pocket that accommodate specific amino acid side chains. Based on analysis of the LdmS enzyme from S. aureus , the following structural features would be critical for SAV_999 specificity:
Active Site Architecture:
The size and shape of the binding pockets for both N-terminal and C-terminal amino acids
The presence of charged residues that form salt bridges with substrate side chains
Hydrophobic patches that interact with nonpolar amino acid side chains
Key Residue Contributions:
Conserved catalytic residues in the ATP-grasp domain that activate the carboxyl group
Specificity-determining residues in the substrate binding pockets
Flexible loop regions that may undergo conformational changes upon substrate binding
Structure-Based Analysis Approach:
X-ray crystallography of SAV_999 in apo form and with bound substrates/substrate analogs
Molecular docking simulations to predict binding modes of various amino acid combinations
Site-directed mutagenesis of predicted specificity-determining residues followed by activity assays
A comparative structural analysis between SAV_999 and enzymes with known structures (such as LdmS) would reveal the molecular basis for its unique substrate preferences .
SAV_999 employs a distinct ATP-dependent mechanism that differentiates it from both ribosomal peptide synthesis and nonribosomal peptide synthetases:
Reaction Mechanism Steps:
Mechanistic Investigation Methods:
Isotope labeling studies to track phosphate transfer
Crystal structures of enzyme complexed with transition state analogs
Kinetic analyses including pH-rate profiles and solvent isotope effects
Site-directed mutagenesis of catalytic residues
Distinguishing Features vs. Other Systems:
Understanding these mechanistic details is crucial for designing inhibitors and for potential biotechnological applications in enzymatic peptide synthesis.
The metabolic role of SAV_999 can be investigated through several complementary approaches:
Genetic Context Analysis:
Metabolomic Profiling:
Compare metabolite profiles between wild-type and SAV_999 knockout strains
Focus on dipeptides and free amino acid pools
Quantify potential substrate and product levels under various growth conditions
Physiological Significance Studies:
Growth phenotypes of knockout mutants under various nutrient limitations
Stress response analysis (oxidative, acid, heat)
Competition assays with wild-type strains in mixed cultures
Potential Functional Roles:
The high conservation of LAL homologs within specific bacterial lineages suggests an important role in their ecology and physiology .
When encountering contradictory results in substrate specificity studies, a systematic troubleshooting approach is essential:
Sources of Experimental Variation:
Differences in enzyme preparation methods affecting purity or folding
Variations in assay conditions (pH, temperature, buffer composition)
Detection method sensitivity and specificity differences
Substrate quality and potential contamination
Reconciliation Protocol:
Standardize enzyme preparations using identical expression and purification protocols
Perform parallel assays under identical conditions with internal controls
Use multiple, complementary detection methods (HPLC, MS, colorimetric assays)
Consider enzyme concentration effects on apparent specificity
Advanced Analytical Approaches:
Determine kinetic parameters (Km, kcat) for disputed substrates under standardized conditions
Use competition assays with known good substrates to assess relative preferences
Employ isothermal titration calorimetry to measure direct binding affinities
Perform structural studies with different substrates to visualize binding modes
Table 2: Framework for Resolving Contradictory Substrate Specificity Data
| Parameter | Approach | Expected Outcome |
|---|---|---|
| Enzyme purity | SDS-PAGE, Size exclusion chromatography | >95% homogeneity |
| Enzyme activity | Standard substrate control assays | Consistent specific activity between preparations |
| Substrate verification | HPLC/MS analysis of amino acid stocks | >99% purity, correct stereochemistry |
| Detection limits | Standard curve with synthetic dipeptides | Linear range and LOD/LOQ for each method |
| Reproducibility | Minimum triplicate independent assays | CV <15% between assays |
This systematic approach will identify the sources of variation and establish reliable substrate specificity profiles .
Accurate kinetic modeling of SAV_999 activity requires consideration of its unique bi-substrate reaction mechanism:
Recommended Kinetic Models:
Sequential Bi-Bi mechanism (either ordered or random)
Rate equations accounting for both amino acid substrates and ATP
Product inhibition effects, particularly by ADP
Experimental Design for Kinetic Analysis:
Initial velocity measurements at varying concentrations of both amino acids
ATP concentration series at fixed amino acid levels
Product inhibition studies with ADP and synthesized dipeptides
Data Analysis Workflow:
Plot primary data as Michaelis-Menten curves
Generate secondary plots (Lineweaver-Burk, Eadie-Hofstee) to identify mechanism
Fit data to appropriate rate equations using nonlinear regression
Calculate key parameters: Km values for each substrate, kcat, and substrate specificity constants (kcat/Km)
Interpretation Guidelines:
Compare parameters with related enzymes like YwfE and LdmS
Evaluate catalytic efficiency in context of biological function
Consider physiological substrate concentrations when interpreting Km values
Assess substrate inhibition effects at high concentrations
Table 3: Expected Kinetic Parameters for SAV_999 Based on Related LALs
| Parameter | Typical Range | Biological Significance |
|---|---|---|
| Km (first amino acid) | 0.1-5 mM | Reflects binding pocket architecture |
| Km (second amino acid) | 0.5-10 mM | Often higher than first substrate |
| Km (ATP) | 0.05-0.5 mM | Consistent with cellular ATP levels |
| kcat | 0.5-20 min⁻¹ | Slower than many metabolic enzymes |
| Ki (ADP) | 1-10 mM | Indicates sensitivity to energy status |
| pH optimum | 7.5-8.5 | Reflects catalytic residue pKa values |
This detailed kinetic characterization will provide insights into the catalytic mechanism and biological role of SAV_999 .
Advanced computational methods can accelerate the discovery of novel substrates for SAV_999:
Structure-Based Computational Approaches:
Homology modeling of SAV_999 based on related LAL structures
Molecular docking of virtual amino acid libraries
Molecular dynamics simulations to assess binding stability
Quantum mechanical calculations of transition state energetics
Machine Learning Prediction Methods:
Train models on known substrate specificity data from related LALs
Feature extraction from physicochemical properties of amino acids
Classification algorithms to predict substrate acceptance probability
Model validation using experimental testing of top predictions
Integration with Experimental Validation:
Select diverse candidates from computational predictions
Prioritize testing based on prediction confidence scores
Use high-throughput screening methods for initial validation
Detailed kinetic characterization of confirmed novel substrates
Application to Dipeptide Library Design:
Design minimal substrate sets that maximize chemical diversity
Predict novel dipeptides with potentially interesting biological activities
Guide the development of SAV_999 variants with altered specificity
This integrated computational-experimental approach can significantly accelerate substrate discovery while reducing the experimental burden of exhaustive screening .
Researchers working with SAV_999 should be aware of several common challenges:
Challenge: Peptide Degradation During Assays
Problem: Contaminating peptidases in enzyme preparations degrading products
Solution: Use highly purified enzyme preparations and include peptidase inhibitors in reaction mixtures
Verification: Compare results from crude extracts vs. purified enzyme and include control reactions with synthetic dipeptides
Challenge: Low Activity or Inconsistent Results
Problem: Enzyme instability, cofactor limitations, or suboptimal conditions
Solution: Optimize buffer conditions (pH, ionic strength), include stabilizing additives (glycerol, BSA), ensure excess ATP and Mg²⁺
Verification: Include positive control reactions with known good substrates in every experiment
Challenge: Difficult Product Detection
Problem: Low sensitivity or specificity in analytical methods
Solution: Use multiple complementary detection methods (HPLC, MS, ninhydrin-based detection)
Verification: Prepare standard curves with synthetic dipeptides to determine detection limits and linear ranges
Challenge: ATP Hydrolysis Background
Problem: Non-productive ATP hydrolysis confounding activity measurements
Solution: Measure ADP formation in parallel with dipeptide formation
Verification: Calculate ATP:dipeptide stoichiometry to confirm mechanism
Table 4: Troubleshooting Guide for SAV_999 Assays
| Issue | Possible Causes | Diagnostic Test | Solution |
|---|---|---|---|
| No activity detected | Inactive enzyme | Test with known good substrate | Verify proper folding, check for inhibitors |
| Activity loss during storage | Enzyme denaturation | Activity time course at different temperatures | Add stabilizers, store as glycerol stock at -80°C |
| Variable replicates | Pipetting errors, enzyme precipitation | Check enzyme homogeneity, use internal standards | Standardize mixing protocol, maintain enzyme solubility |
| Non-linear kinetics | Substrate/product inhibition | Vary enzyme concentration | Reduce reaction time, lower substrate concentrations |
This troubleshooting framework addresses the most common challenges encountered in LAL enzymatic assays .
Optimizing recombinant expression requires addressing several key factors:
Expression Host Selection:
E. coli BL21(DE3): Standard choice, high expression levels
E. coli Rosetta: Better for genes with rare codons
E. coli SHuffle: Enhanced disulfide bond formation if needed
Comparative expression trials in multiple strains recommended
Expression Vector Optimization:
Culture Conditions Optimization:
Temperature: Lower temperature (15-25°C) often increases soluble protein yield
Induction timing: Optimize OD600 at induction (typically 0.6-0.8)
Induction strength: Titrate IPTG concentration (0.1-1.0 mM)
Media composition: Rich media (TB, 2xYT) vs. minimal media for isotope labeling
Purification Strategy Refinement:
Two-step purification combining affinity chromatography with size exclusion or ion exchange
Buffer optimization to maintain stability (typically include glycerol, reducing agents)
Activity assays at each purification step to track specific activity
Table 5: Expression Optimization Strategy for SAV_999
| Parameter | Variables to Test | Expected Impact |
|---|---|---|
| Host strain | BL21(DE3), Rosetta, Arctic Express | Solubility, expression level |
| Growth temperature | 15°C, 25°C, 37°C | Folding efficiency, inclusion body formation |
| Induction OD600 | 0.4, 0.6, 0.8, 1.0 | Cell density, protein yield |
| IPTG concentration | 0.1, 0.25, 0.5, 1.0 mM | Expression level, toxicity |
| Induction time | 4h, 8h, 16h | Accumulation vs. degradation |
| Lysis method | Sonication, French press, chemical | Enzyme activity preservation |
This systematic optimization approach should yield milligram quantities of active enzyme suitable for comprehensive biochemical characterization .
Enhancing SAV_999 solubility and stability requires a multi-faceted approach:
Buffer Optimization Protocol:
Perform stability screening across pH range (6.0-9.0)
Test various buffer systems (Tris, HEPES, phosphate) at different concentrations
Evaluate ionic strength effects (50-500 mM NaCl)
Screen stabilizing additives (glycerol, sorbitol, arginine, glutamic acid)
Protein Engineering Approaches:
Surface entropy reduction: Replace flexible, solvent-exposed residue clusters with alanines
Disulfide engineering: Introduce stabilizing disulfide bonds at appropriate positions
Consensus design: Align sequences of thermostable homologs and incorporate consensus residues
Directed evolution: Random mutagenesis followed by stability screening
Storage and Handling Recommendations:
Avoid freeze-thaw cycles by preparing single-use aliquots
Add protein stabilizers (10-20% glycerol, 1 mM DTT)
Determine optimal protein concentration range (dilute vs. concentrated)
Consider lyophilization with appropriate excipients for long-term storage
Advanced Stability Characterization:
Differential scanning fluorimetry to determine melting temperature
Limited proteolysis to identify flexible/unstable regions
Size exclusion chromatography to monitor aggregation propensity
Activity half-life measurements at different temperatures
By systematically addressing these factors, researchers can significantly improve the handling properties of recombinant SAV_999, enabling more reliable experimental outcomes and extended storage stability .